Zotide Injection (Teriparatide) | Forteo | Used to Treat Osteoporosis in Men/Women at High Risk for Fractures

Precautions

Important precautions for Zotide Injection (Teriparatide)

Bone and metabolic precautions

• Use only for prescribed duration as advised by doctor
• Not recommended beyond the maximum treatment period (typically limited use)
• Regular monitoring of calcium levels is required
• May increase calcium levels in blood (hypercalcemia risk)

Cancer and bone disease precautions

• Not recommended in patients with bone cancers or metastases
• Avoid use in individuals with Paget’s disease of bone
• History of skeletal malignancy requires strict medical evaluation
• Inform doctor about any unexplained bone pain or lumps

Kidney and urinary precautions

• Use cautiously in patients with kidney impairment
• Monitor kidney function during therapy if advised
• Increased calcium may affect kidney stone risk
• Maintain adequate hydration during treatment

Cardiovascular precautions

• May cause dizziness or drop in blood pressure after injection
• Rise slowly from sitting or lying position after administration
• Use caution in patients with heart disease
• Report fainting or palpitations immediately

General usage precautions

• Must be administered under medical supervision
• Do not self-inject without proper training
• Store as per instructions, usually refrigerated
• Rotate injection sites to avoid local reactions

Safety overview table

Usage

Dosage

The recommended dose is 20 mcg once daily.

Administration

• Self-Injection: Your healthcare provider will train you on how to use the pen device properly before your first dose.

• Timing: Administer at the same time each day for consistency.

• Inspection: Check the solution before injecting; it should be clear and colorless. Do not use if it is cloudy, discolored, or contains particles.

• Disposal: Dispose of used needles in a designated "sharps" container according to local regulations.

Uses

• Treatment of Postmenopausal Osteoporosis: Indicated for women with severe osteoporosis who are at high risk of fracture.

• Increase in Bone Mass in Men: Used to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture.

• Glucocorticoid-Induced Osteoporosis: Used in men and postmenopausal women who are at high risk for fracture associated with sustained systemic glucocorticoid therapy.

• Bone Microarchitecture Improvement: Specifically targets the internal structure of the bone, enhancing microarchitecture to reduce the risk of future fractures.

• Anabolic Bone Therapy: Serves as a primary treatment for patients who do not respond to or cannot tolerate traditional antiresorptive therapies.

Side effects

Common side effects

• Nausea
• Headache
• Dizziness
• Leg cramps

Calcium related effects

• Increased calcium levels (hypercalcemia)
• Increased thirst
• Constipation
• Muscle weakness

Cardiovascular effects

• Drop in blood pressure after injection
• Palpitations
• Lightheadedness or fainting (especially initially)
• Flushing

Musculoskeletal effects

• Joint pain
• Limb pain
• Back pain
• Muscle aches

Injection site effects

• Redness or swelling
• Pain at injection site
• Itching or irritation
• Mild bruising

Less common side effects

• Fatigue
• Depression or mood changes
• Nausea with loss of appetite
• Increased uric acid levels

Serious side effects (rare)

• Severe hypercalcemia
• Severe allergic reactions (rash, swelling, breathing difficulty)
• Kidney stone formation
• Persistent or severe bone pain

Side effects summary table

FAQs

Q: What is Zotide Injection used for?

A: Zotide Injection, containing Teriparatide, is a prescription medication used for treating osteoporosis in individuals at high risk of fractures. It helps build new bone and improve bone strength.

Q: How is Zotide administered?

A: Zotide is administered as a daily subcutaneous (under the skin) injection, typically into the thigh or abdominal wall. It comes in a pre-filled pen device designed for easy at-home use.

Q: How long do I need to take this medication?

A: Treatment with Teriparatide is generally limited to a total of 24 months over a patient's lifetime. Your doctor will determine the appropriate duration based on your bone density results and overall health.

Q: What are the common side effects?

A: Common side effects include nausea, joint pain, muscle cramps, dizziness, and mild pain or redness at the injection site.

Q: Can I take this with other osteoporosis medications?

A: Zotide is often used as a standalone treatment. However, your doctor may transition you to an antiresorptive medication (like a bisphosphonate) after your course of Zotide is completed to maintain the bone density gains you have achieved.

Q: How should I store the injection pen?

A: Zotide pens must be stored in the refrigerator (2°C to 8°C) at all times. Do not freeze the medication, and do not use it if it has been frozen.

Q: Are there any serious warnings I should be aware of?

A: Yes. Because teriparatide stimulates bone cell growth, it is not recommended for patients who have an increased risk of bone cancer (such as those with Paget's disease of bone, unexplained elevations of alkaline phosphatase, or prior radiation therapy involving the skeleton).

Q: What should I do if I miss a dose?

A: If you miss a dose, take it as soon as you remember on that same day. Do not take more than one injection on the same day to make up for a missed dose.

Interactions

Drug interactions of Zotide Injection (Teriparatide)

Calcium and bone metabolism medicines

• Calcium supplements may increase risk of high calcium levels (hypercalcemia)
• Vitamin D preparations can enhance calcium absorption and may raise calcium levels
• Other osteoporosis medicines may have additive effects on bone metabolism
• Monitoring of calcium levels is recommended during combined use

Diuretics and kidney related medicines

• Thiazide diuretics may increase blood calcium levels
• Loop diuretics may affect calcium balance differently and require monitoring
• Drugs affecting kidney function may influence calcium handling
• Kidney function should be observed in at-risk patients

Cardiovascular medicines

• Medicines that lower blood pressure may increase dizziness risk
• Diuretics may enhance dehydration or electrolyte imbalance
• Patients should be monitored for blood pressure fluctuations

Hormonal and metabolic medicines

• Other parathyroid-related treatments may alter calcium balance
• Thyroid and steroid medications may affect bone metabolism
• Combination therapy requires careful medical supervision

General medication considerations

• Avoid combining with self-prescribed calcium or vitamin D in high doses
• Herbal supplements affecting calcium or bone health should be disclosed
• Always inform doctor about all prescription and non-prescription drugs

Drug interactions table